{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:36:22Z","timestamp":1792100182508,"version":"4.4.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondation de France (FR)","award":["00061941"],"award-info":[{"award-number":["00061941"]}]},{"name":"Embassy of France","award":["Bourse Passerelle"],"award-info":[{"award-number":["Bourse Passerelle"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0163796","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T14:02:38Z","timestamp":1476972158000},"page":"e0163796","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Development of a Web-Based Clinical Decision Support System for Drug Prescription: Non-Interventional Naturalistic Description of the Antipsychotic Prescription Patterns in 4345 Outpatients and Future Applications"],"prefix":"10.1371","volume":"11","author":[{"given":"Sofian","family":"Berrouiguet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Barrig\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Ovejero-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"\u00c1lvarez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jose","family":"Carballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Courtet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MEmind Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Baca-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"S Leucht","year":"2013","journal-title":"The Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.4088\/JCP.14com09755","article-title":"Does indication drive use, or does use drive indication?","volume":"76","author":"J Lauriello","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"ref3","unstructured":"Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia\u2014NEJM [Internet]. [cited 21 Dec 2015]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa051688\" xlink:type=\"simple\">http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa051688<\/ext-link>"},{"key":"ref4","article-title":"Future Research Needs for First\u2014and Second- Generation Antipsychotics for Children and Young Adults. Future Research Needs Paper No. 13. (Prepared by the RTI -UNC Evidence-based Practice Center under Contract No. 290 2007 10056 I.) [Internet]","author":"R Christian","year":"2012"},{"key":"ref5","first-page":"CD003476","article-title":"The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer\u2019s disease","author":"C Ballard","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pds.2082","article-title":"Increasing off-label use of antipsychotic medications in the United States, 1995\u20132008","volume":"20","author":"GC Alexander","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1176\/appi.ps.005482012","article-title":"Use of administrative data to identify off-label use of second-generation antipsychotics in a Medicaid population","volume":"64","author":"DM Hartung","year":"2013","journal-title":"Psychiatr Serv Wash DC"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-244X-5-26","article-title":"Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics","volume":"5","author":"D Faries","year":"2005","journal-title":"BMC Psychiatry"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/NMD.0b013e31825bfd95","article-title":"Antipsychotic Monotherapy and Polypharmacy in the Treatment of Outpatients With Schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study","volume":"200","author":"D Novick","year":"2012","journal-title":"J Nerv Ment Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.psc.2012.06.007","article-title":"Antipsychotic Polypharmacy","volume":"35","author":"CU Correll","year":"2012","journal-title":"Psychiatr Clin North Am"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2146\/ajhp130471","article-title":"Polypharmacy with antipsychotic drugs in patients with schizophrenia: trends in multiple health care systems","volume":"71","author":"F Sun","year":"2014","journal-title":"Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4088\/JCP.08m04912gre","article-title":"Persistent Antipsychotic Polypharmacy and Excessive Dosing in the Community Psychiatric Treatment Setting: A Review of Medication Profiles in 435 Canadian Outpatients","volume":"71","author":"RM Procyshyn","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","article-title":"Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends","volume":"21","author":"L Carton","year":"2015","journal-title":"Curr Pharm Des"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hup.2257","article-title":"Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics","volume":"27","author":"F Centorrino","year":"2012","journal-title":"Hum Psychopharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10198-011-0308-0","article-title":"Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis","volume":"13","author":"L Baandrup","year":"2012","journal-title":"Eur J Health Econ HEPAC Health Econ Prev Care"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1177\/0269881110379288","article-title":"The incidence and associated risk factors for sudden unexplained death in psychiatric in-patients in England and Wales","volume":"25","author":"K Windfuhr","year":"2011","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1056\/NEJMsa0802005","article-title":"Electronic health records in ambulatory care\u2014a national survey of physicians","volume":"359","author":"CM DesRoches","year":"2008","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9343(03)00057-3","article-title":"A cost-benefit analysis of electronic medical records in primary care","volume":"114","author":"SJ Wang","year":"2003","journal-title":"Am J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJMp0911734","article-title":"Can electronic clinical documentation help prevent diagnostic errors?","volume":"362","author":"GD Schiff","year":"2010","journal-title":"N Engl J Med"},{"key":"ref20","first-page":"7","article-title":"Healthcare IT usability and suitability for clinical needs: challenges of design, workflow, and contractual relations","volume":"157","author":"R Koppel","year":"2010","journal-title":"Stud Health Technol Inform"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0010-4809(84)90011-9","article-title":"Evaluation of a computerized drug review system: impact, attitudes, and interactions","volume":"17","author":"C Siegel","year":"1984","journal-title":"Comput Biomed Res Int J"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139403","article-title":"A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona","volume":"10","author":"AM Gaviria","year":"2015","journal-title":"PLoS ONE"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-151-5-200909010-00141","article-title":"Toward reuse of clinical data for research and quality improvement: the end of the beginning?","volume":"151","author":"MG Weiner","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/amiajnl-2011-000681","article-title":"Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research","volume":"20","author":"NG Weiskopf","year":"2013","journal-title":"J Am Med Inform Assoc JAMIA"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/MLR.0b013e31829b1dbd","article-title":"Caveats for the use of operational electronic health record data in comparative effectiveness research","volume":"51","author":"WR Hersh","year":"2013","journal-title":"Med Care"},{"key":"ref26","article-title":"Tenth revision of the International Classification of Diseases and related health problems (ICD-10)","year":"1992"},{"key":"ref27","unstructured":"WHOCC\u2014Structure and principles [Internet]. [cited 4 Dec 2014]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.whocc.no\/atc\/structure_and_principles\/\" xlink:type=\"simple\">http:\/\/www.whocc.no\/atc\/structure_and_principles\/<\/ext-link>"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(98)00105-4","article-title":"Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials","volume":"35","author":"S Leucht","year":"1999","journal-title":"Schizophr Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.60.6.553","article-title":"A meta-analysis of the efficacy of second-generation antipsychotics","volume":"60","author":"JM Davis","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3928\/02793695-20130709-01","article-title":"Efficacy of quetiapine off-label uses: data synthesis","volume":"51","author":"AC Carney","year":"2013","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/phar.1529","article-title":"A Literature Review of Quetiapine for Generalized Anxiety Disorder","volume":"35","author":"T-JM Kreys","year":"2015","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/phar.1204","article-title":"Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature","volume":"33","author":"BM Wright","year":"2013","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1517\/13543784.2010.538048","article-title":"Therapeutic potential of new second generation antipsychotics for major depressive disorder","volume":"19","author":"SL McElroy","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2146\/ajhp130221","article-title":"Quetiapine for insomnia: A review of the literature","volume":"71","author":"SL Anderson","year":"2014","journal-title":"Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm"},{"key":"ref35","first-page":"S1","article-title":"Summary of the comparative effectiveness review on off-label use of atypical antipsychotics","volume":"18","author":"AR Maher","year":"2012","journal-title":"J Manag Care Pharm JMCP"},{"key":"ref36","first-page":"323","article-title":"Analysis of prescription patterns of antipsychotic agents in psychiatry","volume":"34","author":"AL Montejo","year":"2006","journal-title":"Actas Esp Psiquiatr"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.4088\/JCP.v67n0902","article-title":"Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review","volume":"67","author":"K Gao","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s11920-014-0534-0","article-title":"Pharmacotherapy for borderline personality disorder\u2014current evidence and recent trends","volume":"17","author":"JM Stoffers","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-010-1939-z","article-title":"Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials","volume":"212","author":"S Gentile","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/JCP.0b013e3181e7810a","article-title":"Antipsychotic Agents for the Treatment of Substance Use Disorders in Patients With and Without Comorbid Psychosis","volume":"30","author":"S Zhornitsky","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"ref41","first-page":"283","article-title":"Utilizing pharmacodynamic properties of second-generation antipsychotics to guide treatment","volume":"48","author":"T Schwartz","year":"2012","journal-title":"Drugs Today Barc Spain 1998"},{"key":"ref42","first-page":"333","article-title":"Polipharmacy in the antipsychotic prescribing in practices psychiatric out-patient clinic","volume":"32","author":"G Florez Men\u00e9ndez","year":"2004","journal-title":"Actas Esp Psiquiatr"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-244X-12-42","article-title":"Antipsychotic polypharmacy in a regional health service: a population-based study","volume":"12","author":"M Bernardo","year":"2012","journal-title":"BMC Psychiatry"},{"key":"ref44","year":"2009"},{"key":"ref45","article-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"D Taylor","year":"2012"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/2045125314540298","article-title":"Factors associated with non evidence-based prescribing of antipsychotics","volume":"4","author":"A Connolly","year":"2014","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref47","article-title":"Cochrane Database of Systematic Reviews","author":"M Berk","year":"1996"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/hup.574","article-title":"Dosage finding and outcome in the treatment of schizophrenic inpatients with amisulpride. Results of a drug utilization observation study","volume":"19","author":"M Linden","year":"2004","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2165\/00044011-200828080-00001","article-title":"Practical Issues with Amisulpride in the Management of Patients with Schizophrenia","volume":"28","author":"PL Pani","year":"2008","journal-title":"Clin Drug Investig"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2004-827174","article-title":"High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study","volume":"37","author":"K Sim","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0004867413488221","article-title":"Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison","volume":"48","author":"D Roh","year":"2014","journal-title":"Aust N Z J Psychiatry"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1177\/0091270009350625","article-title":"Antipsychotic Polypharmacy in Outpatients at Birch Hill Hospital: Incidence and Adherence to Guidelines","volume":"50","author":"N Ranceva","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jbi.2012.09.002","article-title":"Interface design principles for usable decision support: a targeted review of best practices for clinical prescribing interventions","volume":"45","author":"J Horsky","year":"2012","journal-title":"J Biomed Inform"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1197\/jamia.M1370","article-title":"Ten Commandments for Effective Clinical Decision Support: Making the Practice of Evidence-based Medicine a Reality","volume":"10","author":"DW Bates","year":"2003","journal-title":"J Am Med Inform Assoc JAMIA"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/PTS.0b013e31821d6f6e","article-title":"Critical drug-drug interactions for use in electronic health records systems with computerized physician order entry: review of leading approaches","volume":"7","author":"DC Classen","year":"2011","journal-title":"J Patient Saf"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e71325","DOI":"10.1371\/journal.pone.0071325","article-title":"A Smartphone Ecological Momentary Assessment\/Intervention \u201cApp\u201d for Collecting Real-Time Data and Promoting Self-Awareness","volume":"8","author":"JD Runyan","year":"2013","journal-title":"PloS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0163796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T06:57:32Z","timestamp":1540018652000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0163796"}},"subtitle":[],"editor":[{"given":"Therese","family":"van Amelsvoort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,20]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0163796","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,20]]}}}